Background. Chronic post-thoracotomy pain (CPP) has a high incidence. However, less is known about risk factors and the influence of different analgesia therapies.
Methods. In this prospective cohort study, patients either received standardized epidural analgesia or began an oral analgesic protocol with controlled-release oxycodone immediately postoperatively. Patients answered a baseline questionnaire on the day before surgery and a follow-up questionnaire six months postoperatively. The questionnaire included Short-Form 12, the Neuropathic Pain Scale, and descriptive questions for CPP. Pain protocols of all patients were examined. Logistic regression was used to analyze the risk factors related to CPP.
Results. One hundred seventy-four patients were enrolled; data of 131 patients were available after the six-month follow-up period. Fifty-one patients (39%) had CPP six months postoperatively. Of these, more than 80% had impaired daily activity or ability to work, or reported sleeping disturbance due to CPP. The strongest predictive factors for the development of CPP were: thoracic pain for three months preoperatively (odds ratio [OR] 5 3.54, 95% confidence interval [CI] 5 1.69-7.40, P 5 0.001), thoracic pain for 12 months preoperatively (OR 5 2.73, 95% CI 5 1.28-5.83, P 5 0.009), and higher pain scores at rest in the first five postoperative days compared with patients without CPP (OR 5 1.79, 95% CI 5 1.24-2.57, P 5 0.002). Neuropathic pain was present in 4.8% of patients. Patients with CPP had a reduced physical (P 5 0.005) and mental health status (P 5 0.03) six months after surgery compared with patients without CPP.
Conclusions. Preoperative thoracic pain and higher pain scores in the first five postoperative days seem to be the strongest risk factors for the development of CPP. CPP patients reported poorer mental and physical health before and six months after surgery.
Introduction
Chronic post-thoracotomy pain (CPP) is defined as persistent pain for at least two months after thoracic surgery [1] . Previous studies have shown CPP to be present in 25% to 70% of cases [2] [3] [4] [5] [6] . The incidence of neuropathic pain in CPP has not yet been determined [2, 4, 7, 8] . Risk-factor analyses for postoperative pain have been performed for various surgical procedures [9] [10] [11] . Retrospective data have identified parameters such as age less than 60 years, female gender, preexisting hypertension, and duration of chest-tube drainage as risk factors for CPP [4] . Recently published prospective data showed that extrathoracic pain, in particular in the neck/shoulder area, lower back, hips or knees, or more than three body regions may affect the development of post-thoracotomy pain [12] . However, there is still little deep knowledge derived from prospective data.
The aim of this prospective study was to evaluate risk factors for the development of CPP. Furthermore, we analyzed the impact of CPP on patients' mental and physical health status and the incidence of neuropathic pain in CPP.
Methods

Subjects and Procedure
After obtaining local research committee approval (University of Essen, Chairperson Prof. Jakobs, 08-3745) and written informed consent, 174 patients were enrolled in our prospective study from November 2013 to March 2014, conducted according to the Declaration of Helsinki standard.
Eligible patients were those scheduled for elective anteroaxillary thoracotomy or video-assisted thoracoscopy (VATS), age 18-80 years. Patients with known contraindications to epidural analgesia (EDA), dipyrone, or oxycodone were excluded. Further exclusion criteria were communication difficulties, pregnancy, and drug abuse. At the hospital, patients were offered an epidural catheter for thoracotomy and VATS. If the patient had contraindications or was not willing to have an epidural catheter, pain therapy was followed by an oral opioid protocol.
Anteroaxillary thoracotomy is the standard surgical approach in our thoracic center and is performed via the fourth intercostal space; the serratus muscle is not dissected, but retracted. The thoracic cavity is closed with three pericostal sutures. In VATS, in general, two incisions are made for the trocars, and a third incision for the optical device. At the end of both types of surgery, one or two 24 CH soft chest tubes are placed.
Pain therapy is standardized in our thoracic center. If a thoracic epidural catheter (Braun Melsungen) is inserted, it is placed before induction of anesthesia at thoracic level 5/6 or 6/7. After administering a test dose of 3 mL 0.25% bupivacaine, a continuous epidural infusion is begun at 4-8 mL/hour. The standard epidural drug combination is ropivacaine 0.2% with 0.75 mg/mL sufentanil (500 mL bag). Thirty minutes before the end of the surgical procedure, all patients receive 1-2 g IV dipyrone, a nonopioid analgesic frequently used in the perioperative setting in Germany according to German acute pain treatment guidelines. Patients are then admitted to the intensive care unit (ICU) or recovery area and receive 1 g dipyrone every six hours. EDA is continued at 4-8 mL/hour. If analgesia is not sufficient, as indicated by cold-pressor test, patients are switched to a systemic analgesia regimen before admission to the general ward. If analgesia is still inadequate after a bolus of 6 mL ropivacaine 0.75%, the epidural catheter is removed. On the second postoperative day (POD), the regimen is changed to 0.5 g dipyrone four times daily by mouth. The EDA is continued at 4-8 mL/hour until the 500 mL bag is empty, and patients are then placed on a standardized pain treatment protocol with controlledrelease oxycodone/naloxone (Targin) 20-0-10 mg per day and oral dipyrone 0.5 g every six hour. Patients without an epidural catheter receive 5-10 mg IV piritramide, an opioid with approximately 0.7 times the potency of IV morphine, at the end of surgery. After discharge from the ICU or recovery area, these patients receive a standardized opioid protocol with controlledrelease oxycodone/naloxone (Targin) 30-0-20 mg initially and then 20-0-10 mg and 0.5 g by mouth.
Pain scores at rest and on coughing are evaluated every six hours. If the numerical rating scale (NRS 0-10; 0 ¼ no pain, 10 ¼ worst pain imaginable) score is 4 or higher during rest, IV rescue medication (parecoxib 40 mg) is administered to patients in both protocols. Thirty minutes after administration of rescue medication, the NRS score is re-assessed. If it is still more than 4, the nurse must contact the anesthesiologist responsible for postoperative pain therapy. The anesthesiologist examines the patients to exclude other causes than wound pain and increases opioid dose if necessary. All patients are visited daily by an anesthesiologist during their stay in hospital, and pain medication is adjusted as needed.
Assessment
A baseline questionnaire was filled in on the ward on the day before surgery, and the follow-up questionnaire was done six months postoperatively. The questionnaires were sent to the patients by mail; if they were not returned within four weeks, the patients were contacted by telephone. The baseline questionnaire included the following variables:
• Short-Form-12 (SF-12): a generic instrument measuring the mental and physical parameters of healthrelated quality of life [13] .
• Chronic pain in any location persisting for more than three months.
• Chronic thoracic pain in any location persisting for more than three months.
• Chronic thoracic pain in any location persisting for more than 12 months.
During their postoperative hospital stay, during daily visits the pain intensity at rest and during coughing (NRS 0-10) was documented.
The six-month questionnaire included:
• SF-12.
• The 10-item neuropathic pain scale (NPS), which characterizes the main clinical signs and symptoms of neuropathic pain. The NPS score is converted to a score ranging from 0 to 100 and comprises three categories: "no neuropathic pain" (0-40 points), "possible" (42-53 points), and "probable" (54-100 points) neuropathic pain [14] .
• Questions with regard to CPP:
᭺ Intensity of CPP (NRS 0-10). ᭺ CPP-related impairment of daily activity, ability to work, leisure activities, mood, and sleeping habits (NRS 0-10). Duration of thoracic pain persisting after discharge if it was no longer present. ᭺ Analgesic use.
CPP was defined as any pain NRS greater than 0 in the thoracic wound area six months after surgery.
In March 2015, we sent a postal inquiry to the local residents' registration offices to determine whether death was the reason for missing questionnaires.
Statistical Analysis
All variables were analyzed by methods of descriptive statistics (frequency, mean 6 standard deviation, range). In order to test differences between means, the Student's t-test was applied in cases of normal distribution; otherwise the Mann-Whitney-U test was adopted. For discriminating between normal and non-normal distributed variables, the Kolmogoroff-Smirnoff test was applied. Levene's test was used to assess the equality of variance in different samples. We applied the x 2 test to compare frequencies and proportions in two groups. Logistic regression was used to model the association between different variables suspected to influence the development of chronic pain. To measure acute postoperative pain, the average pain intensity at rest and during coughing at the first five postoperative days were analyzed. We considered P values of less than 0.05 to be statistically significant. Statistical analysis was performed using SPSS 22.0 software (SPSS Inc., Chicago, IL, USA).
Results
A total of 174 patients were enrolled in this prospective study and completed the baseline questionnaire on the day before surgery. The demographic data are presented in Table 1A . The local residents' registration offices confirmed the deaths of 18 patients: 25 did not complete the follow-up questionnaire. Patients' diagnoses are presented in Table 1B .
Quality of CPP
NRS score data of 131 patients were available on the six-month follow-up questionnaire: Seventy-one (54%) patients reported thoracic pain in the three months before the follow-up investigation. Fifty-one patients (39%) had CPP, defined as pain persisting for more than six months after surgery. Of those patients, 35 were diagnosed with intra-or extrathoracic malignancies (18 with preoperative diagnosis and 17 diagnosed by intraoperative biopsies).
Out of these CPP patients, 26% reported mild (NRS 1-3), 35% moderate (NRS 4-6), and 4% severe (NRS 7-10) pain intensity ( Table 2) . Thirty-three patients had taken analgesic drugs in the past four weeks, and 18 had not. Of the 80 patients without CPP, 33 had taken analgesic medication in the past four weeks and 47 had not. Of the 51 patients with CPP six months postoperatively, 39 (76%) felt impaired in their daily activity (dressing, washing), 86% in their ability to work, 84% in leisure activities and hobbies, 88% in their mood, and 84% had disturbances of their sleeping habits. Three patients stated that they had pain for less than one week after discharge from hospital, 20 patients for one to two weeks, 21 for two to four weeks, 18 for one to two months, and 10 for two to three months after discharge.
Risk Factors for CPP
In the preoperative questionnaire, 116 patients (67%) reported having preoperative pain in any location. Thirtynine (33.6%) of these patients developed CPP (not significant); 53 reported having thoracic pain three months preoperatively. More patients with thoracic pain for more than three months preoperatively developed CPP than patients without preoperative thoracic pain (P < 0.001) ( Table 4) , and more patients with thoracic pain for more than 12 months preoperatively developed CPP than patients without preoperatively thoracic pain (P < 0.01) ( Table 3) . Patients with CPP demonstrated higher average pain scores during the first five postoperative days at rest (P < 0.003) and on coughing (P < 0.03) than patients without CPP six months postoperatively.
There was no gender difference in CPP (P ¼ 0.07) ( Table 4) . Univariate odds ratios identified female gender as a predictive factor for the development of CPP (Table 4 ). There was no significant difference in CPP incidence between patients with EDA and those with oral opioid therapy (Table 3 ). There was no significant difference in opioid dose on the day of discharge from hospital between patients with and without CPP six months postoperatively (Table 3 ). There was a tendency toward a lower incidence of CPP in patients after VATS compared with open thoracotomy, which, however, did not reach statistical significance (P ¼ 0.09). Table 2 Pain intensity of chronic postthoracotomy pain at six months' follow-up (N ¼ 131) 
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Patients with CPP had a reduced physical (P ¼ 0.005) ( Table 4 ) and mental health status compared with patients without CPP (P ¼ 0.03), as shown in Tables 3  and 4 .
Discussion
Surgical procedure-specific pain management is regarded as one step toward the improvement of pain management in general, with the additional intention of reducing the incidence of chronic postsurgical pain [15] . However, to date no in-depth, prospective risk factor analysis for CPP has been performed in details.
Recently published prospective data showed that extrathoracic pain, most frequently that in the neck/shoulder area, lower back, hips or knees, or more than three body regions may influence the development of postthoracotomy pain [12] . In contrast to these findings, we found preoperative thoracic, but not extrathoracic, pain to be the major risk factor for the development of chronic pain after thoracotomy. Thoracic pain present 12 and three months preoperatively showed the strongest predictive power for CPP.
We found that our patients with CPP after six months had significantly higher pain scores at rest and on coughing in the first five PODs than those who did not develop CPP, independent of whether they had received an epidural-or opioid-based pain regimen postoperatively. However, although they are statistically significant, the absolute differences in those pain scores are low. From our point of view, this fact underlines the necessity of a highly effective postoperative pain therapy to avoid the development of chronic post-thoracotomy pain.
A recently published systematic review of therapeutic interventions to reduce acute and chronic postsurgical pain after amputation, thoracotomy, and mastectomy found that local anesthetics and regional anesthesia may reduce the severity of chronic pain [16] . Analyzing our different pain concepts-EDA vs systemic analgesia-we could not demonstrate a difference in outcome with regard to the development of chronic pain. Our results indicate that higher postoperative pain intensity, rather than the analgesic technique used, appears to be a predictive factor for developing CPP. We would like to emphasize that our patients undergo standardized, intense pain therapy throughout their stay in hospital. Our data indicate that systemic oral pain therapy with a long-acting opioid might control postoperative pain following thoracotomy as effectively as EDA [17] [18] [19] [20] . Peng et al. found duration of chest tube drainage to be a risk factor for CPP [4] . However, we did not collect data on chest tube drain duration, which might have had an effect on our data that we cannot definitely exclude.
In the present study, we found an incidence of postoperative neuropathic pain in 4.8% of cases, and possible neuropathic pain in 8.8%, using the NPS. This finding confirms our previous results that indicated a low incidence of neuropathic pain measured by the painDETECT questionnaire [17, 18] . Recently published retrospective data found an incidence of neuropathic pain of 32.5% using a linguistic adaption of three routinely used neuropathic pain questionnaires [4] , which raises the question of whether the existing questionnaires for neuropathic pain are in fact appropriate tools for assessing neuropathic pain after thoracotomy.
Chronic pain patients reported poorer mental and physical health before and six months after surgery. Our results confirm other authors' retrospective data on pain.
Our study is limited by a number of factors: As in most surveys and questionnaires, a response bias cannot be excluded. We had to accept a dropout rate of approximately 25%, which might have led to a nonresponse bias in our results. Another possible limitation might be the single-center design of our study. Recall bias is probable when asking patients six months later to remember the duration of their pain after discharge. However, this gives a rough estimation of the duration of persisting pain after surgery that did not last up to six months.
In conclusion, we present the first prospective data on risk factors for CPP from a standardized setting in regard to surgical procedure and postoperative analgesia throughout the patients' complete hospital stay. Our findings indicate that preoperatively existing thoracic pain and higher pain scores in the first five postoperative days are the strongest predictive factors for the development of CPP. Chronic pain patients also reported poorer mental and physical health before and six months after surgery.
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